Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
Giuseppe Procino, Monica Carmosino, Serena Milano, et al.
Kidney International (2016) Vol. 90, Iss. 3, pp. 555-567
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask)
Giorgia Schena, Michael J. Caplan
Cells (2019) Vol. 8, Iss. 4, pp. 357-357
Open Access | Times Cited: 113
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
Serena Milano, Monica Carmosino, Andrea Gerbino, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2385-2385
Open Access | Times Cited: 76
Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic Kidney Diseases
Mi Ra Noh, Hee‐Seong Jang, Jinu Kim, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1647-1647
Open Access | Times Cited: 33
Nephrogenic diabetes insipidus: a comprehensive overview
Pedro Alves Soares Vaz de Castro, Letícia Bitencourt, Juliana Lacerda de Oliveira Campos, et al.
Journal of Pediatric Endocrinology and Metabolism (2022) Vol. 35, Iss. 4, pp. 421-434
Closed Access | Times Cited: 21
The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
Maurizio Cammalleri, Rosario Amato, Massimo Dal Monte, et al.
Pharmacological Research (2023) Vol. 190, pp. 106713-106713
Open Access | Times Cited: 11
Anesthesia-induced Lymphatic Dysfunction
Randal O. Dull, Robert G. Hahn, Gabriella E. Dull
Anesthesiology (2024) Vol. 141, Iss. 1, pp. 175-187
Closed Access | Times Cited: 4
β3‐Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation
Martin C. Michel, Ebru Arioglu‐Inan, Martin Hennenberg
Neurourology and Urodynamics (2025)
Open Access
β‐Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3‐adrenoceptors
Massimo Dal Monte, Maura Calvani, Maurizio Cammalleri, et al.
British Journal of Pharmacology (2018) Vol. 176, Iss. 14, pp. 2496-2508
Open Access | Times Cited: 31
TRPML1-Induced Lysosomal Ca2+ Signals Activate AQP2 Translocation and Water Flux in Renal Collecting Duct Cells
Simona Scorza, Serena Milano, Ilenia Saponara, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1647-1647
Open Access | Times Cited: 9
Autosomal Dominant Polycystic Kidney Disease Therapies on the Horizon
Julie Zhou, Vicente E. Torres
Advances in Kidney Disease and Health (2023) Vol. 30, Iss. 3, pp. 245-260
Closed Access | Times Cited: 8
Nephrogenic diabetes insipidus
Detlef Böckenhauer, Daniel G. Bichet
Current Opinion in Pediatrics (2017) Vol. 29, Iss. 2, pp. 199-205
Closed Access | Times Cited: 28
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
Xia Zhou, Vicente E. Torres
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway
Mingbing Xiao, Dan-Dan Jin, Yujie Jiao, et al.
Molecular Biology Reports (2018) Vol. 45, Iss. 6, pp. 1863-1871
Closed Access | Times Cited: 21
New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus
Hyun Jun Jung, Tae‐Hwan Kwon
Kidney Research and Clinical Practice (2019) Vol. 38, Iss. 2, pp. 145-158
Open Access | Times Cited: 20
The β3‐AR agonist BRL37344 ameliorates the main symptoms of X‐linked nephrogenic diabetes insipidus in the mouse model of the disease
Serena Milano, Ilenia Saponara, Andrea Gerbino, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
Mirabegron, dependent on β3-adrenergic receptor, alleviates mercuric chloride-induced kidney injury by reversing the impact on the inflammatory network, M1/M2 macrophages, and claudin-2
Mahmoud M. Kamal, Hanan S. El‐Abhar, Dalaal M. Abdallah, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111289-111289
Closed Access | Times Cited: 6
Pharmacologic management of nocturnal polyuria: a contemporary assessment of efficacy, safety, and progress toward individualized treatment
Thomas F. Monaghan, Jeffrey P. Weiss, Karel Everaert, et al.
Therapeutic Advances in Urology (2021) Vol. 13, pp. 175628722098843-175628722098843
Open Access | Times Cited: 14
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease
Jean‐Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 11, pp. 1031-1031
Open Access | Times Cited: 5
Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?
Haneen S. Dwaib, Martin C. Michel
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 5
β3 adrenergic receptor as potential therapeutic target in ADPKD
Giorgia Schena, Monica Carmosino, Samantha Chiurlia, et al.
Physiological Reports (2021) Vol. 9, Iss. 20
Open Access | Times Cited: 12
β3-Adrenoceptor as a new player in the sympathetic regulation of the renal acid–base homeostasis
Serena Milano, Ilenia Saponara, Andrea Gerbino, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 1
The vasopressin–aquaporin-2 pathway syndromes
Giovanna Valenti, Grazia Tamma
Handbook of clinical neurology (2021), pp. 249-259
Closed Access | Times Cited: 10
β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
Serena Milano, Fatima Maqoud, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1136-1136
Open Access | Times Cited: 3
Nephrogenic Diabetes Insipidus
András Balla, László Hunyady
Experientia supplementum (2019), pp. 317-339
Open Access | Times Cited: 8
Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway
Bohong Cen, Wenjie Liao, Zhen Wang, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 11, pp. 300-311
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top